Safety in Industry 4.0 – Are you prepared for the Automation?

Safety in Industry 4.0 – Are you prepared for the Automation?

With the rapid change of the modern world into an ‘Industry 4.0’ economy, it can be said that the change is somewhat similar to the Industrial revolution of the 18th century. Industries have undergone a significant change in terms of production and optimization of the whole process, things like machine learning; AI i.e. artificial intelligence and automation are the primary cause. As the process is getting better and mature there is the introduction of cyber-physical systems, cloud computing, and cognitive/behavioral computing all this gives rise to certain specific problems which…

Read More

Bravatek Solutions Signs Partnership Agreement for IIOT Technology

Bravatek Solutions Signs Partnership Agreement for IIOT Technology

AUSTIN, Texas, June 25, 2019 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — Bravatek Solutions, Inc. (OTC Pink: BVTK) (“Bravatek” or the “Company”) declared that it entered into an arrangement with MC smart controls, Inc. to display and advertise its IIOT technology on an absolute basis to customers like policymakers and military. Along with this, BVTK will advertise its products on a non-absolute basis to manufacturers of systems that have a demand to be connected to the Internet. IIOT goes far beyond the regular customer devices because of its connection via communication…

Read More

Microba Partners with Korean Company Macrogen to Develop Global Microbiome Service Offering

Microba Partners with Korean Company Macrogen to Develop Global Microbiome Service Offering

Australian biotech giant Microba has made an alliance with Macrogen to develop microbiome research services for the offshore market. An MOU has got signed at the Macrogen Headquarters in Seoul on 14 March 2019 defining all the partnership terms and condition. Through this MOU, Macrogen and Microba will establish a close cooperation system. With this partnership, they will try to penetrate into the microbiome market of Korea and other nations Macrogen is a significant Korean company which has a market capitalization of 350m USD and annual revenues touching 100m USD….

Read More

Deal of Zymeworks up to $1.2bn Announced by J&J Biospecific Antibody

Deal of Zymeworks up to $1.2bn Announced by J&J Biospecific Antibody

Johnson & Johnson and Zymeworks have done a deal by which Johnson & Johnson will pay Zymework $50m to license it as well as to develop around six therapeutic agents. Jansen will have all the ownership and responsibilities for all research development and commercialization of the outcome. According to Zymework’s CEO Ali Tehrani, the license is not exclusive for any targets. Zymeworks will receive a potential $282m in development and up to $1.12bn in milestone payments and royalties. Jansen has also the option to develop two additional bispecific programs subject…

Read More

The Bispecific and Complex mAbs Driving Process Development Innovation, Roche

The Bispecific and Complex mAbs Driving Process Development Innovation, Roche

According to a statement by the VP of Roche technical development bioprocessing, Wolfgang Kuhne said that the older processes used to produce monoclonal antibodies like Herceptin and Avastin are not sufficient to produce complex and advanced pharmaceuticals. A bioprocess international European summit was held in Vienna, Austria during which delegates were told that making candidates like ACE910 – a bispecific antibody granted breakthrough designation for Haemophilia last September – had required a considerable process development effort. In his statement, he clarified by saying “There are no more classical standard approaches…

Read More

Discussing effective, novel technology and recent discoveries of translational neuroscience in London

Discussing effective, novel technology and recent discoveries of translational neuroscience in London

London, UK, June 20th, 2019 – 5th Annual MarketsandMarkets Neuroscience R&D Technologies Conference will be discussing the latest technologies in the preclinical, translational neuroscience space. The conference will take place on 3rd and 4th October 2019 in London, UK also brings attention to new innovations of translational neuroscience imaging. This is a first ever conference focusing on applications of technology in developing neurological treatments where you will be able to meet global neuroscience heads from industry and academia. over the 2-days, 20+ industry leading speakers will be sharing their research &…

Read More

MarketsandMarkets Industry 4.0 Conference: Cyber Security & IIoT Invites Cyber Security & IIoT Experts and Leaders in Chicago

MarketsandMarkets Industry 4.0 Conference: Cyber Security & IIoT Invites Cyber Security & IIoT Experts and Leaders in Chicago

Chicago, May 31 – Focused on the impact of two technologies i.e, Cyber Security & IIoT, on manufacturers, MarketsandMarkets Industry 4.0 Conference: Cyber Security & IIOT, is addressing a series of application-based illustrations and discussions to map the future possibility of trends in the manufacturing world. Discussing solutions to the challenges faced, see the future of manufacturing from leading experts and industry leaders presenting their proven strategies and solutions. The 2-day conference starting from September 23, 2019 to September 24, 2019 in Chicago – USA, will provide a platform to…

Read More

Thermo Fisher Scientific Acquires HighChem, Provider of Mass Spectrometry Software

Thermo Fisher Scientific Acquires HighChem, Provider of Mass Spectrometry Software

Thermo Fisher Scientific, the world leader in serving science, announces the completion of the acquisition of a very well-known leading developer named HighChem Ltd. of the software mass spectrometry which is situated at Bratislava, Slovakia. HighChem offers software solutions at its best which are used for analyzing complex data and helps in identifying small molecules in metabolomics & pharmaceutical laboratories. As per their recorded words of Mitch Kennedy, the President of Thermo Fisher Scientific (Mass Spectrometry & Chromatography), “the company is working on providing a great surface to their customers…

Read More

Improved version in CAR T-cell therapy seems to eliminate its serious side effects

Improved version in CAR T-cell therapy seems to eliminate its serious side effects

A USC study shows an improved version of CAR T-cell therapy seems to eliminate its serious side effects, which will make the treatment safer and potentially available in outpatient settings. Si – Yi Chen of the USC Norris Comprehensive Cancer Center, professor in the Department of Molecular Microbiology and Immunology at the Keck School of Medicine of USC, and senior author of the study said, “This is a major improvement”. He further added “We’ve made a new CAR molecule that’s just as efficient at killing cancer cells, but it works…

Read More

Discussing Challenges and Opportunities in AI & Fintech at The 2nd Edition MarketsandMarkets AI & Fintech Conference.

Discussing Challenges and Opportunities in AI & Fintech at The 2nd Edition MarketsandMarkets AI & Fintech Conference.

MarketsandMarkets is organizing its 2nd Edition AI & Fintech Conference in San Francisco on May 16-17, 2019 discussing the hidden opportunity for FinTech, the impact of AI on FinTech and how AI is unlocking new lending opportunities. With attendance of experts from Banks, Hedge Funds, Insurance companies, Financial institutions, Stock Broking firms, Wealth Management firms etc. this two-day event will host use cases of Fintech, Blockchain from leading banks, financial services companies and technology providers along with innovative & emerging FinTech start-ups. San Francisco, April 2– MarketsandMarkets Presents to you…

Read More